Evidence map›Paper›PMID 25197532›Full record

ArticleMiddle East journal of digestive diseases2011

Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome.

H Nobakht, F Zamani, H Ajdarkosh, Z Mohamadzadeh, Sm Fereshtehnejad, M Nassaji

Abstract read
In one paragraph

Article in Middle East journal of digestive diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Rheumatology training and research in Iran.Rheumatology international · 2019
    Pooled it
  2. Trial
  3. Comparison of Clinical and Genetic Characteristics of Familial Mediterranean Fever Patients Among Adult Age Groups.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  4. Article
  5. Autoinflammatory manifestations in adult patients.Clinical and experimental immunology · 2022
    Article
  6. Article
  7. Spectrum ofMedical sciences (Basel, Switzerland) · 2020
    Article
  8. Article
  9. Periodic fever syndromes and the autoinflammatory diseases (AIDs).Journal of translational autoimmunity · 2020
    Review
  10. Clinical and genetic heterogeneity in a large cohort of Armenian patients with late-onset familial Mediterranean fever.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Article
  11. A rare cause of fever in an adult: a case of familial Mediterranean fever.International medical case reports journal · 2018
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

H NobakhtAssistant Professor of Gastroenterology and Hepatology, Fatemieh hospital, Semnan University of Medical Sciences, Semnan, Iran.
F ZamaniAssociate Professor of Gastroenterology and Hepatology, Firoozgar Hospital, Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran University of Medical Sciences, Tehran, Iran.
H AjdarkoshAssistant Professor of Gastroenterology and Hepatology, Firoozgar Hospital, Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran University of Medical Sciences, Tehran, Iran.
Z MohamadzadehResearch Fellow, Imam-Khomeini General Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.
Sm FereshtehnejadResearch Fellow, Firoozgar Hospital, Gastrointestinal and Liver Disease Research Center (GILDRC), Tehran University of Medical Sciences, Tehran, Iran.
M NassajiAssistant Professor of Infectious Diseases, Fatemieh hospital, Semnan University of Medical Sciences, Semnan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by sporadic, paroxysmal attacks of fever and serosal inflammation. Although the disease usually begins before the age of 20 years, we aimed to evaluate the demography, clinical features and treatment outcome of familial Mediterranean fever in Iranian adult patients above 20 years old. METHODS In this cross-sectional study, adult patients (first attack at the age of >20 years) with a diagnosis of FMF who referred to the gastroenterology and rheumatology Clinics of Ardebil University of Medical Science (situated in north west of Iran) over the period of 2004-2009 were enrolled. FMF diagnosis was based on clinical criteria. RESULTS Forty four FMF patients (30 male and 14 female) with the mean [± Standard Deviation (SD)] age of first attack of 29 ± 7.8 years were enrolled. Abdominal pain (95.5%) and fever (91%) were the most common clinical findings. All of the patients had satisfactorily responded to therapy. Response was complete in 76.7% and partial in 23.3% of the patients. There was no clinical or laboratory evidence of amyloidosis at the time of diagnosis or during follow-up. CONCLUSION Our findings demonstrated that adult-onset FMF in Iran has different characteristics (more common in males, lesser prevalence of arthritis and erysipelas-like erythema, less delay in diagnosis) and treatment outcome (favorable response even to low-dose colchicine) in comparison with the previous data on early onset patients.

Indexed as

Adult onsetClinical featuresFamilial Mediterranean feverTreatment

Identifiers

PMID25197532
PMCPMC4154930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.